Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma

Abstract Background CD73 and CD39, key components of the adenosine axis, are expressed in multiple malignancies; the impact of standard-of-care treatment on their expression and antitumor immunity in esophageal squamous cell carcinoma (ESCC) remains unclear. We evaluated the adenosine axis in the co...

全面介紹

書目詳細資料

發表在:	Discover Oncology
Main Authors:	Zachary A. Cooper, Ying Wang, Philip L. Martin, Kosho Murayama, Rakesh Kumar, Ken Kato, Shun Yamamoto, Shigeki Sekine
格式:	Article
語言:	英语
出版:	Springer 2025-03-01
主題:	Adenosine CD73 Esophageal squamous cell carcinoma Neoadjuvant chemotherapy Neoadjuvant chemoradiotherapy
在線閱讀:	https://doi.org/10.1007/s12672-025-02179-x